TELA Bio (TELA) Equity Average (2018 - 2026)
TELA Bio has reported Equity Average over the past 8 years, most recently at $3.9 million for Q4 2025.
- For Q4 2025, Equity Average fell 64.53% year-over-year to $3.9 million; the TTM value through Dec 2025 reached $3.9 million, down 64.53%, while the annual FY2025 figure was $17.4 million, 26.55% down from the prior year.
- Equity Average for Q4 2025 was $3.9 million at TELA Bio, down from $5.4 million in the prior quarter.
- Over five years, Equity Average peaked at $45.4 million in Q1 2021 and troughed at -$1.7 million in Q3 2024.
- A 5-year average of $18.0 million and a median of $15.9 million in 2022 define the central range for Equity Average.
- Biggest five-year swings in Equity Average: plummeted 104.82% in 2024 and later skyrocketed 415.73% in 2025.
- Year by year, Equity Average stood at $23.9 million in 2021, then dropped by 21.37% to $18.8 million in 2022, then soared by 31.45% to $24.7 million in 2023, then crashed by 55.12% to $11.1 million in 2024, then tumbled by 64.53% to $3.9 million in 2025.
- Business Quant data shows Equity Average for TELA at $3.9 million in Q4 2025, $5.4 million in Q3 2025, and $13.7 million in Q2 2025.